These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32657946)

  • 1. A Novel Immune Modulator for Patients With Necrotizing Soft Tissue Infections (NSTI): Results of a Multicenter, Phase 3 Randomized Controlled Trial of Reltecimod (AB 103).
    Bulger EM; May AK; Robinson BRH; Evans DC; Henry S; Green JM; Toschlog E; Sperry JL; Fagenholz P; Martin ND; Dankner WM; Maislin G; Wilfret D; Bernard AC;
    Ann Surg; 2020 Sep; 272(3):469-478. PubMed ID: 32657946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study.
    Brakenridge SC; Wilfret DA; Maislin G; Andrade KE; Walker V; May AK; Dankner WM; Bulger EM
    J Trauma Acute Care Surg; 2021 Aug; 91(2):384-392. PubMed ID: 33797490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial.
    Bulger EM; Maier RV; Sperry J; Joshi M; Henry S; Moore FA; Moldawer LL; Demetriades D; Talving P; Schreiber M; Ham B; Cohen M; Opal S; Segalovich I; Maislin G; Kaempfer R; Shirvan A
    JAMA Surg; 2014 Jun; 149(6):528-36. PubMed ID: 24740134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and Progression of Organ Dysfunction in Patients with Necrotizing Soft Tissue Infections: A Multicenter Study.
    Bulger EM; May A; Bernard A; Cohn S; Evans DC; Henry S; Quick J; Kobayashi L; Foster K; Duane TM; Sawyer RG; Kellum JA; Maung A; Maislin G; Smith DD; Segalovich I; Dankner W; Shirvan A
    Surg Infect (Larchmt); 2015 Dec; 16(6):694-701. PubMed ID: 26381131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a clinical trial composite endpoint for patients with necrotizing soft tissue infections.
    Bulger EM; May A; Dankner W; Maislin G; Robinson B; Shirvan A
    J Trauma Acute Care Surg; 2017 Oct; 83(4):622-627. PubMed ID: 28538644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Antibiotic Duration after Surgical Debridement of Necrotizing Soft Tissue Infection.
    Kenneally AM; Warriner Z; VanHoose JD; Ali D; McCleary EJ; Davenport DL; Parli SE
    Surg Infect (Larchmt); 2022 May; 23(4):357-363. PubMed ID: 35262418
    [No Abstract]   [Full Text] [Related]  

  • 7. Sweet and Sour: Impact of Early Glycemic Control on Outcomes in Necrotizing Soft-Tissue Infections.
    Beauchamp LC; Mostafavifar LG; Evans DC; Gerlach AT
    Surg Infect (Larchmt); 2019; 20(4):305-310. PubMed ID: 30716012
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocompromised status in patients with necrotizing soft-tissue infection.
    Keung EZ; Liu X; Nuzhad A; Adams C; Ashley SW; Askari R
    JAMA Surg; 2013 May; 148(5):419-26. PubMed ID: 23677405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer Is Associated with a Higher Mortality Rate in Necrotizing Soft Tissue Infections.
    Khoury MK; Pickett ML; Cripps MW; Park SY; Nagaraj MB; Hranjec T; Hennessy SA
    Surg Infect (Larchmt); 2020 Mar; 21(2):136-142. PubMed ID: 31448994
    [No Abstract]   [Full Text] [Related]  

  • 10. Necrotizing soft tissue infections: improved outcomes with modern care.
    Tillou A; St Hill CR; Brown C; Velmahos G
    Am Surg; 2004 Oct; 70(10):841-4. PubMed ID: 15534961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of early surgery and comorbid conditions on outcomes of severe necrotizing soft-tissue infections.
    Latifi R; Patel AS; Samson DJ; Tilley EH; Gashi S; Bergamaschi R; El-Menyar A
    Eur J Trauma Emerg Surg; 2019 Oct; 45(5):919-926. PubMed ID: 29789865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
    Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
    J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperbaric oxygen therapy in necrotizing soft tissue infections.
    Massey PR; Sakran JV; Mills AM; Sarani B; Aufhauser DD; Sims CA; Pascual JL; Kelz RR; Holena DN
    J Surg Res; 2012 Sep; 177(1):146-51. PubMed ID: 22487383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal timing of initial debridement for necrotizing soft tissue infection: A Practice Management Guideline from the Eastern Association for the Surgery of Trauma.
    Gelbard RB; Ferrada P; Yeh DD; Williams BH; Loor M; Yon J; Mentzer C; Khwaja K; Khan MA; Kohli A; Bulger EM; Robinson BRH
    J Trauma Acute Care Surg; 2018 Jul; 85(1):208-214. PubMed ID: 29485428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
    Hansen MB
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-Center Review of Care Patterns and Outcomes in Necrotizing Soft Tissue Infections.
    Faraklas I; Yang D; Eggerstedt M; Zhai Y; Liebel P; Graves G; Dissanaike S; Mosier M; Cochran A
    Surg Infect (Larchmt); 2016 Dec; 17(6):773-778. PubMed ID: 27834617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of Antibiotic Therapy in Necrotizing Soft Tissue Infections: Shorter is Safe.
    Terzian WTH; Nunn AM; Call EB; Bliss SE; Swinarska JT; Rigdon J; Avery MD; Hoth JJ; Miller PR
    Surg Infect (Larchmt); 2022 Jun; 23(5):430-435. PubMed ID: 35451883
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoglobulin for necrotising soft tissue infections (INSTINCT): protocol for a randomised trial.
    Madsen MB; Lange T; Hjortrup PB; Perner A
    Dan Med J; 2016 Jul; 63(7):. PubMed ID: 27399982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiology of necrotizing soft tissue infections.
    Elliott D; Kufera JA; Myers RA
    Am J Surg; 2000 May; 179(5):361-6. PubMed ID: 10930480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.